<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Algorithm for anticoagulant discontinuation in individuals undergoing elective surgery</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Algorithm for anticoagulant discontinuation in individuals undergoing elective surgery</h1>
<div class="graphic"><div class="figure"><div class="ttl">Algorithm for anticoagulant discontinuation in individuals undergoing elective surgery</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Refer to UpToDate for further information on the bleeding risk of common procedures and the thromboembolic risk of common underlying conditions. High thromboembolic risk includes mechanical heart valve, high risk of stroke, or recent venous thromboembolism (within the prior 3 months).</div><div class="graphic_footnotes"><p>DOAC: direct oral anticoagulant; VKA: vitamin K antagonist; CrCl: creatinine clearance; VTE: venous thromboembolism; IVC: inferior vena cava; LMW: low molecular weight.</p>
* Anticoagulants:
<ul>
<li>Direct oral anticoagulants (DOACs) include dabigatran, apixaban, edoxaban, and rivaroxaban.</li>
<li>Vitamin K antagonists include warfarin, acenocoumarol, phenprocoumon, and fluindione.</li>
</ul>
<p class="extra_spacing_top">¶ The following applies to DOAC interruption:</p>
<ul>
<li>These intervals are for individuals with normal kidney function and factor Xa inhibitors regardless of kidney function.</li>
<li>For individuals with CrCl 30 to 50 mL/min receiving dabigatran, longer intervals are used (omit from 2 days before a low/moderate bleeding risk procedure; omit from 4 days before a high bleeding risk procedure).</li>
<li>The perioperative management from the PAUSE study (a population with atrial fibrillation) can be applied to individuals who are receiving a DOAC for VTE that was &gt;30 days prior. If the individual had a VTE within the prior 30 days, DOAC interruption should be individualized and may include placement of a temporary IVC filter or shorter periods of DOAC interruption.</li>
<li>Bridging is not used for DOACs.</li>
</ul>
<p class="extra_spacing_top">Δ The following applies to VKA interruption:</p>
<ul>
<li>For warfarin, discontinue 5 days before the procedure.</li>
<li>If bridging is needed for a high thromboembolic risk patient, start LMW heparin at therapeutic dose approximately 3 days before surgery, with the last preoperative dose approximately 24 hours before surgery.</li>
<li>Resume warfarin postoperatively once hemostasis is assured (typically the evening of the day of surgery or the day after surgery). Resume LMW heparin approximately 2 to 3 days after surgery (determined by the bleeding risk of the procedure) and discontinue LMW heparin after stable warfarin anticoagulation.</li>
<li>The overlap period between LMW heparin and warfarin depends on the patient's thromboembolic risk.</li>
</ul></div><div class="graphic_reference">Based on guidance from A Tafur, J Douketis. Perioperative management of anticoagulant and antiplatelet therapy. Heart 2018; 104:1461.</div><div id="graphicVersion">Graphic 129999 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
